GlassScriptPhysician profile
Joohee Son
NPI 1821656836
$6,756.42
in general payments reported to CMS, 2019-2025
7 companies · $6,584 in 2025
The $6,584 reported for 2025 was more than what 86% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $173 · 2025: $6,584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,717 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,015 · Food and Beverage: $1,796 · Education: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,716.72 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,014.58 |
| Food and Beverage | $1,796.12 |
| Education | $229.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,336.47 | 2024-2025 | Konect Resilia, Inspiris Resilia Aortic Valve, Mitris Resilia Mitral Valve |
| Medtronic, INC. | $2,141.22 | 2025 | Corevalve Evolut R |
| Abbott Laboratories | $1,441.82 | 2025 | Cardiomems |
| Abiomed | $331.76 | 2025 | |
| Atricure, INC. | $207.04 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System, Atriclip Laa Exclusion System |
| On Target Laboratories, INC | $149.90 | 2025 | Cytalux |
| Baxter Healthcare | $148.21 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joohee Son listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.